Brief
Enable the brand team to anticipate future entrants and prepare to launch a new treatment for a rare disease.
Overview
We conducted a 12-month monitoring project of two rare indications in the US and EU with daily alerts and monthly reports.
In addition to monitoring we conducted ad hoc targeted primary research in response to competitor catalyst events adding depth of knowledge and understanding.
Outcome
Initial baseline report outlining the current and future competitive landscape was updated on a monthly basis to reflect changing events. Insights helped to inform the client’s four-year forecast and strategy ahead of their AGM.